RIPPLE
LIVE

Serial Number

99348403

Owner

SonoThera, Inc.

Attorney

Dustin Luettgen

Filing Date

Aug 20, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RIPPLE Trademark

Serial Number: 99348403

RIPPLE is a trademark filed by SonoThera, Inc. on August 20, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

SonoThera, Inc. (7 trademarks)

201 Haskins Way
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

August 20, 2025

Registration Date

Not Registered

Goods & Services

Gene therapy preparations, namely, biological preparations for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology; kits comprised of gene therapies, namely, biological preparations and pharmaceutical preparations both for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology; gene delivery platform in the nature of biological delivery agents, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for the treatment of human diseases and disorders being diseases of genetic and genetic predisposition etiology.

Downloadable computer operating software for operating ultrasound systems and ultrasound probes that are used for administering pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders.

Medical services for ultrasound mediated administration of pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders.

Software as a service (SAAS) services featuring software for operating ultrasound systems and ultrasound probes that administer pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders; research and development in the field of gene therapy.

Ultrasound systems being medical ultrasound apparatus and ultrasound probes for medical use for administering pharmaceutical agents being biological preparations and gene therapy preparations for the treatment of human diseases and disorders.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 23, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 23, 2026 XELR
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 23, 2026 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 23, 2026 PARI
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jan 7, 2026 GPRN
PRIORITY ACTION E-MAILED
Jan 7, 2026 GPRA
PRIORITY ACTION WRITTEN
Jan 7, 2026 CPRA
ASSIGNED TO EXAMINER
Jan 6, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 20, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 20, 2025 NWOS
NEW APPLICATION ENTERED
Aug 20, 2025 NWAP